French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as AccelLAB.

"The acquisition is expected to foster the acquirer’s position in non-clinical contract research and will also help it provide services to the medical devices sector."

The target company is based in Canada and employs approximately 100 people.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

The acquisition is expected to foster the acquirer’s position in non-clinical contract research and will also help it provide services to the medical devices sector.

Sichuan Kelun Pharma, a company based in China, plans to acquire full ownership in a biopharmaceutical company based in Guangxi, in which it already holds 80%, by acquiring the remaining 20% stake.

In another acquisition, the same company plans to acquire a 35% stake in a biopharmaceutical company based in Changshu. The value of the acquisition is estimated to be ¥36m ($5.3m).

See Also:

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.